Chewy vs. Walmart: Which Is the Better Way to Invest in Pet Spending?​

Walmart is presented as the more attractive stock versus Chewy due to a wider competitive moat, broader customer footprint and improving margin drivers from online advertising (global ad sales +53% YoY in Q3 FY26 ended Oct. 31, 2025). Walmart posted ~5.8% YoY revenue growth in Q3 FY26 and typically runs net margins of roughly 3%–4%, while Chewy grew revenue ~8.3% YoY in its Q3 FY25 (ended Nov. 2) but trades at a higher 67 P/E vs. Walmart’s 42 and delivers net margins near ~2%; the piece argues Chewy’s valuation leaves less room for error despite pet-health diversification. The comparison highlights margin dynamics and valuation as the key drivers for investor preference, implying modest reallocations toward Walmart on margin upside from ad monetization and away from a high-P/E Chewy with low single-digit profitability.

Analysis

Market structure: Walmart (WMT) is the structural winner — scale in grocery plus a fast-growing ad product (Q3 FY26 ad sales +53% yoy) converts low-margin retail into higher-margin services, improving potential EBITDA by an estimated 100–150bps over 2–3 years if ad growth stays >30% yoy. Chewy (CHWY) is a loser on current multiples (P/E ~67) because the pet channel is lower-margin (net margins ~2%) and its growth (8.3% yoy) doesn’t justify the valuation unless pet-health margins materially expand.

Risk assessment: Tail risks include regulatory scrutiny of Walmart’s ad targeting (privacy/antitrust) and operational execution risk for Chewy’s vet expansion; a macro pullback (discretionary spend shock) would hit CHWY disproportionately. Timeframes: expect volatility in days/weeks around earnings; medium-term (3–12 months) clarity on margins from ad monetization or vet-rollouts; long-term (3–5 years) determines competitive moat shift.

Trade implications: Favor large-cap retail and ad-exposure over pure-play pet e-commerce. Implement a capital-efficient bias: long WMT exposure and short CHWY as a relative-value trade; use LEAP call exposure on WMT and puts/bear spreads on CHWY to manage volatility and asymmetric payoff. Reallocate 1–4% of portfolio from niche pet names (FRPT/CHWY) into WMT to capture margin uplift.

Contrarian angles: Consensus underestimates speed at which Walmart’s ad mix can re-rate the stock — analog: Amazon’s ad margins expansion — and overestimates Chewy’s margin optionality from vet clinics (requires 3–5 years to scale). Unintended consequences: rapid ad monetization could draw regulator attention or push competitors to subsidize inventory, compressing retail margins; monitor margin inflection points, not just revenue growth.

Key Decisions for Investors

• Establish a 2–3% long position in WMT within 4 weeks (12–18 month horizon). Scale up to 4–5% if Walmart ad revenue growth remains >30% yoy next two quarters and consolidated EBITDA margin improves by >100bps; set tactical stop-loss at -12% from entry.
• Initiate a 1–1.5% short position in CHWY (or equal-dollar to half your WMT long) as a 6–12 month relative-value trade. Cover if CHWY reports net profit margin >4% for two consecutive quarters or if CHWY stock falls ≥40% (take-profit) or rallies >30% (cut loss).
• Buy WMT 12–18 month LEAP calls 15% OTM allocating 0.5–1% of portfolio and buy CHWY 6–9 month puts 20% OTM allocating 0.5% (if IV >40%, use bear-put spread on CHWY to define risk).
• Reduce small-cap/niche pet exposure (e.g., trim FRPT/other pet names by 1–2% of portfolio) and reallocate into large-cap consumer staples/retail (WMT) to capture ad-margin re-rating over next 12–36 months.
• Monitor three specific catalysts weekly: (1) WMT global ad sales growth — signal if >30% yoy, (2) CHWY vet/pet-health EBITDA margin trajectory — signal if margin >5% within 18 months, (3) consumer staples basket CPI (food at-home) — signal if >+3% yoy; adjust positions within 7 trading days of threshold breach.